WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8'4801 Infant (under 12 months) mortality rate: 262
GDP / capita (US$): 8'8581 Child (under 5 years) mortality rate: 302

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 535  530  525  520  515  467  407  366 
Births 10  10  10  10  10  11  10  11 
Surviving infants 10  10  10  11 
Pop. less than 5 years 46  47  48  48  49  50  47  46 
Pop. less than 15 years 149  149  150  151  150  143  136  146 
Female 15-49 years 140  139  137  137  136  123  104  87 

Number of reported case

(Click for retrospective incidence data for Suriname)
Diphtheria
Japanese encephalitis
Measles 35  254 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 40  11 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Suriname)
Vaccine year result method % card seen                                                
BCG         
DTP1 2005  96  MICS   81.2  80  90  99  91  95 
DTP3 2005  91  MICS   81.2  84  86  96  87  85  71  83  25 
HepB_BD          84  36  69 
HepB3 2005  MICS   81.2  84  86  86  87  84 
Hib3 2005  MICS   81.2  84  86  86  87  84 
JapEnc         
MCV 2009  78  MICS   81.6  73  85  90  88  86  71  65 
MCV2         
PCV1         
PCV3         
Pol3 2009  83  MICS   81.6  84  86  96  85  85  70  81  24 
Rota1         
Rota_last         
Rubella1          73  85  99  88  86 
TT2plus 2009  27  MICS   81.6  30 
PAB         
VAD1         
YFV 2009  64  MICS   81.6  73  81  80 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Suriname)
DTP1 94  90  99  91  95  90  94  50 
DTP3 84  86  96  87  85  71  83  25 
HepB3 84  86  86  87  84 
Hib3 84  86  86  87  84 
MCV 73  85  90  88  86  84  65 
PAB 93  93  93  93  93  92  92 
PCV3
Pol3 84  86  96  85  85  70  81  24 
Rota_last
YFV 73  10  11  11  11 

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT > 5 years; Yes booster
DTwP 18 months; 4 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HPV Yes From October 2013
HepB birth; Yes HCW (x3 doses)
Influenza Yes Older persons, chronic diseases, healthcare workers, pregnant women
MMR 1, 4 years; Yes
OPV 2, 4, 6, 18 months; 4 years; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 1 year;

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  Yes  No  No  Yes 
What years does the MYP cover? number             All EPI 
Nº of districts with microplans that include activities to raise immunization coverage number     10   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 10  10  10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   90  90  80  90  90 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%   20  40  10     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.